Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 21 - 30 of about 124   

Articles published

GSK 1,473.00 -16.00 (-1.07%)
price chart
How GlaxoSmithKline plc & SkyePharma PLC Can Turbocharge Your Returns
On the face of it, GlaxoSmithKline (LSE: GSK) looks like the perfect investment. The company is one of the world's largest pharmaceutical groups, which owns a vast consumer products business, highly profitable vaccines business and pharmaceuticals ...
Can You Trust HSBC Holdings plc's Dividend Or Should You Pick GlaxoSmithKline plc?
HSBC (LSE: HSBA) and GlaxoSmithKline (LSE: GSK) are two of the FTSE 100's dividend champions. HSBC's shares currently support a dividend yield of 8.5%, and Glaxo's shares support a dividend yield of 5.4%. The question is, can these yields be trusted?
Analysts Observing Recap: Sarepta Therapeutics, Inc. (NASDAQ:SRPT ...
GlaxoSmithKline PLC (NYSE:GSK) after beginning at $43.63, closed at $43.47 by building up +1.78% in recent trading session.
Will GlaxoSmithKline plc, Alliance Pharma plc And Smith & Nephew plc Keep ...
In the last month, Alliance Pharma (LSE: APH) has outperformed the FTSE 100 by over 6%. This index-beating performance could continue, with the company today releasing an upbeat set of results that show it's on track to deliver improved profitability ...
3 High-Yield Dividend Stocks For The Next Bear Market: GlaxoSmithKline plc ...
When stock markets go awry, high yield stocks tend to outperform the broader market. The high-yielding dividend stocks that perform best in a downturn are so-called defensive ones.
GlaxoSmithKline plc 3% Potential Upside Indicated by Jefferies International
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Retains' with the recommendation being set at 'HOLD' today by analysts at Jefferies International.
GlaxoSmithKline plc (LON:GSK) Receives GBX 1506.17 Consensus PT from Brokerages  The Vista Voice
GlaxoSmithKline plc (GSK) Given "Hold" Rating at Liberum Capital  Mas Market News
PREVIEW: Can AstraZeneca follow Glaxo with better-than-expected quarterlies?
AstraZeneca Plc (LON:AZN) releases its first quarter results Friday, though analysts reckon it has been a 'relatively uneventful' quarter.
Myocarditis Pipeline Report 2016 - Review of CEL-SCI Corporation ...
This report provides comprehensive information on the therapeutic development for Myocarditis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and ...
Promising stocks in today's market: GlaxoSmithKline plc (NYSE:GSK)
Based on the aggregate value of the company over its current share price and the total amount of outstanding stocks, the market cap of GlaxoSmithKline plc is presently reeling at 105654.45. Acting as the blue chip in today's trade, GlaxoSmithKline plc ...
CMA slaps GlaxoSmithKline plc (ADR)(NYSE:GSK) with a �37.6 million ($54 ...
The justification by the Competitions and Market Authority (CMA) of having slapped GlaxoSmithKline plc (ADR)(NYSE:GSK) with a �37.6 million ($54 million) fine is that the company was mortified of a pay-for-delay scheme for its now off-patent ...
GlaxoSmithKline plc (NYSE:GSK) lost about 0 percent in value since last earnings  Zergwatch
Jefferies Group Analysts Boost Earnings Estimates for GlaxoSmithKline plc (GSK)  The Vista Voice